Zhejiang East Asia Pharmaceutical Gains South Korea's Nod for Acid Reflux Tablets

MT NewswiresMay 11 17:53

East Asia Pharmaceutical (605177.SH): Its wholly-owned subsidiary has obtained the Korean API registration certificate for the raw material of Fumaric Acid Vonoprazan.

Gelonghui, May 8th - East Asia Pharmaceutical (605177.SH) announced recently that Jiangxi Shanyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhejiang East Asia Pharmaceutical Co., Ltd., has received the active pharmaceutical ingredient registration certificate from the Korean Ministry of Food and Drug Safety (Korean MFDS). Vonoprazan fumarate is a potassium-competitive acid blocker (P-CAB) which inhibits gastric acid production and prevents damage to the upper gastrointestinal mucosa. It is mainly used in the treatment of gastroesophageal reflux disease and, when combined with appropriate antibiotics, for the eradication of Helicobacter pylori. Relevant data shows that the nationwide sales revenue of formulations related to vonoprazan fumarate is projected to reach approximately 7 billion yuan by 2025.

Gelonghui FinanceMay 8 15:36

East Asia Pharmaceutical: First Quarter Report for 2026

SZSIApr 30 00:00 · Announcements

East Asia Pharmaceutical Co., Ltd. First Quarter Report for 2026

SZSIApr 30 00:00 · Announcements

East Asia Pharmaceuticals (605177.SH) reported a net loss of 35.2017 million yuan in the first quarter.

According to the report by Gelonghui on April 29, East Asia Pharmaceutical (605177.SH) released its Q1 2026 earnings report, showing that the company achieved operating revenue of 265 million yuan in the first quarter, representing a year-on-year increase of 38.58%; net profit attributable to shareholders was -35.2017 million yuan, compared to -6.9196 million yuan in the same period last year; non-recurring net profit attributable to shareholders was -38.6365 million yuan.

Gelonghui FinanceApr 29 17:37

East Asia Pharmaceutical: Summary of East Asia Pharmaceutical\'s 2025 Annual Report

SZSIApr 23 00:00 · Announcements